(lp0
S"Horizon Fights Par Pharma's Generic Of Urine Disorder Drug Law360  - Jul 1, 2016 Horizon Therapeutics Inc. claims Par Pharmaceutical Inc. infringed its three Ravicti patents when it applied for an abbreviated new drug application with the Food and Drug Administration."
p1
aS'Analyst Recommendations And Earnings Forecast: Horizon Global Corporation (HZN ... Post Analyst - Mar 17, 2017 Horizon Global Corporation  has made its way to a 12-month gain of 21.92%. Turning to INSYS Therapeutics, Inc. , its shares were trading at $10.06 a retreat of $-0.49, on the trading floor. The stock, after opening at $10.46, touched ...'
p2
aS'New Drugs for Insys Therapeutics Inc  and Horizon Pharma PLC Lead ... Smarter Analyst - Jul 6, 2016 Healthcare companies Insys Therapeutics Inc  and Horizon Pharma PLC  both received bullish sentiments from analysts this past week.Insys Therapeutics  Stock Soars on FDA Approval - TheStreet.com'
p3
aS"Buzz Stocks: Sears Holdings Corp, Horizon Pharma PLC, and Voyager Therapeutics Inc Schaeffers Research  - Dec 8, 2016 Among specific equities in focus today are retail stock Sears Holdings Corp , as well as drugmakers Horizon Pharma PLC  and Voyager Therapeutics Inc . Here's a quick look at what's driving SHLD, HZNP,&nbsp;...Horizon Pharma slumps as Friedreich's ataxia drug Phase III trial fails - The Pharma Letter "
p4
aS'Stemline Therapeutics  Reaches $8.70 After 5.00% Up Move, Kingdon ... Herald KS - 14 hours ago Horizon Pharma PLC  has declined 37.30% since August 15, 2016 and is downtrending. It has underperformed by 44.33% the S&amp;P500.The Numeric Investors LLC Takes Position in Horizon Pharma PLC  - Petro Global News 24Horizon Pharma PLC  Position Lowered by Federated Investors Inc. PA - BNB Daily '
p5
aS'BUZZ-US STOCKS ON THE MOVE-Intel, Horizon, Gordmans, Sunworks Nasdaq - Mar 13, 2017 [nL3N1GQ3OY] ** OSIRIS THERAPEUTICS INC &lt;OSIR.O&gt;, $4.25, -18.27 pct The regenerative medicine developer said on Friday it received a letter from the Nasdaq notifying that its stock will be suspended from trading on March 14.US STOCKS ON THE MOVE-Intel, Horizon, Gordmans, Sunworks - Times of India'
p6
aS"Pain Therapeutics' Remoxy ER Secures FDA Regulatory Guidance  Investopedia - Mar 21, 2017 has announced securing positive regulatory guidance from the U.S. Food And Drug Administration  for its lead drug candidate Remoxy ER , which paves the way for expeditious progress toward resubmission&nbsp;..."
p7
aS'Wall Street Cheers These Two Rising Stocks: Esperion Therapeutics Inc (ESPR ... Smarter Analyst - Mar 20, 2017 Esperion Therapeutics Inc  and Nektar Therapeutics  are skyrocketing with a fury today on back of major clinical strides forward that have investors today eagerly watching these needle-movers ascend up through the stratosphere ...'
p8
aS"OilPrice.com: The Next Big Biotech Breakthrough Could Just be on the Horizon PR Newswire  - Mar 13, 2017 A comment that sent Amicus Therapeutics Inc. stocks jump 17%, trading more than three times the average volume, after Trump used the CEO's daughter as a case study during his address to Congress."
p9
aS'Flexion Therapeutics Inc Realized Volatility Hits A Lowered Level CML News - Feb 27, 2017 This is a proprietary realized volatility rating created by Capital Market Laboratories  based on a large number of data interactions for Flexion Therapeutics Inc  . We examine the little used gem of daily stock volatility over a ...'
p10
a.